HROW News and Press, Harrow Health Inc. From 11/15/23

2023-11-15 00:33:34 ET Summary Harrow is a company focused on eye health with a strong distribution platform and CEO ownership. Q3 earnings were below expectations, and guidance was lowered, raising concerns about operational performance. However, the company has lots of oppor...

2023-11-14 14:22:16 ET Gainers: BioCardia ( BCDA ) +170% . reAlpha Tech Corp. ( AIRE ) +119% . Turnstone Biologics Corp ( TSBX ) +75% . Theseus Pharmaceuticals ( THRX ) +49% . American Coastal Insurance Corp ( ACIC ) +38% . M...

2023-11-14 13:31:57 ET More on Harrow Health Harrow, Inc. (HROW) Q3 2023 Earnings Call Transcript Implications Of Harrow's Short-Term Guidance Harrow Health's 5-Year Guidance Biggest stock movers today: Home Depot, Fisker, Snap, Beauty Health Company and more...

2023-11-14 08:10:54 ET More on pre-market losers Financial information for Collective Audience, Inc. Financial information for E-Home Household For further details see: EJH and CAUD among pre-market losers

2023-11-14 05:00:20 ET Related stories: The Beauty Health Company (SKIN) Q3 2023 Earnings Call Transcript Harrow, Inc. (HROW) Q3 2023 Earnings Call Transcript Fisker, Inc. (FSR) Q3 2023 Earnings Call Transcript For further details see: Biggest stock mover...

2023-11-13 21:25:23 ET Harrow, Inc. (HROW) Q3 2023 Earnings Conference Call November 13, 2023 16:45 ET Corporate Participants Jamie Webb - Director-Communications & Investor Relations Mark Baum - Chief Executive Officer Andrew Boll - Chief Financial Officer ...

2023-11-13 18:01:34 ET Gainers: Theseus Pharmaceuticals ( THRX ) +35% . GENFIT  ( GNFT ) +15% . Lifeway Foods ( LWAY ) +9% . Digital World Acquisition ( DWACW ) +8% . Digital World Acquisition  ( DWAC ) +5% . Lose...

2023-11-13 16:08:09 ET More on Harrow Health Implications Of Harrow's Short-Term Guidance Harrow Health's 5-Year Guidance Seeking Alpha’s Quant Rating on Harrow Health Historical earnings data for Harrow Health Financial information for Harrow ...

Third Quarter 2023 and Recent Selected Highlights: Record revenues of $34.3 million, an increase of 50% over $22.8 million in the prior-year quarter and an increase of 2% over $33.5 million in the sequential quarter. GAAP net loss of $(4.4 million). Adjusted EBITDA of $9.2 million, ...

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...